» Articles » PMID: 30535368

Reconsidering the Cut-off Diastolic Blood Pressure for Predicting Cardiovascular Events: a Nationwide Population-based Study from Korea

Overview
Journal Eur Heart J
Date 2018 Dec 12
PMID 30535368
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: It is unclear whether a J-curve association exists in cardiovascular risk prediction and how independently systolic and diastolic blood pressure (BP) predict cardiovascular outcomes. This study evaluated the association of systolic and diastolic BP with major cardiovascular events to clarify these issues.

Methods And Results: Antihypertensive medication-naïve subjects with available BP measurements and no history of cardiovascular events were extracted from the National Health Insurance Services Health Screening Cohort. The study endpoint was a composite of cardiac death, myocardial infarction, stroke, and heart failure. The study population comprised 290 600 subjects (median follow-up duration 6.7 years). The risk for major cardiovascular events was lowest at systolic and diastolic BPs of 90-99 mmHg and 40-49 mmHg, respectively, above which BPs demonstrated a log-linear risk prediction. Systolic and diastolic BPs were highly correlated. The risk prediction of diastolic BP was inconsistent when stratified by systolic BP. A wider pulse pressure rather than a higher diastolic BP was significantly associated with cardiovascular outcomes among men aged ≥55 years. In addition, the difference between diastolic BPs of <80 mmHg and 80-89 mmHg mostly disappeared after statistical adjustment or stratification.

Conclusion: Elevated BP is a strong predictor of future cardiovascular events including cardiac death, myocardial infarction, stroke, and heart failure. This study showed that the log-linear relationship between BP and cardiovascular events extended down to a BP of ≥90/40 mmHg. Although hypertension is defined using a lower systolic BP cut-off of ≥130 mmHg, the diastolic BP component of ≥80 mmHg seems disproportionately low.

Citing Articles

Risk factors associated with SGLT2 inhibitor discontinuation in diabetic patients with heart failure.

Kim M, Heo S, Kim M, Park J, Bae S, Roh J PLoS One. 2024; 19(11):e0314305.

PMID: 39585835 PMC: 11588271. DOI: 10.1371/journal.pone.0314305.


2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.

Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y Acta Cardiol Sin. 2024; 40(5):479-543.

PMID: 39308649 PMC: 11413940. DOI: 10.6515/ACS.202409_40(5).20240724A.


Risk factors of in-hospital mortality and discriminating capacity of NIVO score in exacerbations of COPD requiring noninvasive ventilation.

Zhang J, Yi Q, Zhou C, Luo Y, Wei H, Ge H Chron Respir Dis. 2024; 21:14799731241249474.

PMID: 38652928 PMC: 11041537. DOI: 10.1177/14799731241249474.


Factors associated with cardiovascular disease: A comparative study of the UK Asian diaspora and residents of India.

Patel M, Uthman O PLoS One. 2024; 19(4):e0301889.

PMID: 38625950 PMC: 11020392. DOI: 10.1371/journal.pone.0301889.


The value of earlier-in-life systolic and diastolic blood pressure for cardiovascular risk prediction.

Leiherer A, Brozek W, Muendlein A, Ulmer H, Saely C, Fraunberger P iScience. 2024; 27(3):109097.

PMID: 38384855 PMC: 10879708. DOI: 10.1016/j.isci.2024.109097.